“…Notably, studies in RTT mouse models have suggested that cell autonomous and non-cell autonomous mechanisms drive neuronal morphology and function [229,230,231]. In addition, recent in vitro models of RTT using MECP2 -deficient neurons derived from human pluripotent stem cells have recapitulated many neurological features of RTT [232,233,234,235,236], and have also shown neuronal migration defects [236] (Table 1). Interestingly, in contrast to the majority of the ASD-associated mTORopathies, neurons from Mecp2 −/− and Mecp2 +/− mice [43], as well as from MECP2 -deficient human pluripotent stem cells [233], show decreased mTORC1 signaling activity, transcription and protein synthesis rate.…”